Pharmaceutical Services Unit Essential Medicines Management

Slides:



Advertisements
Similar presentations
THE CHALLENGES & OPORTUNITIES OF ACCESS TO MEDICINES IN AFRICA Dr Pascoal MOCUMBI, orig Mozambique,High Representative EDCTP ABRASCO/WFPHA.
Advertisements

1 Policy options to address access to chronic disease medicines Dr. Richard Laing Ms. Alexandra Cameron Department of Essential Medicines and Pharmaceutical.
Strategies to Improve Efficiency in Medicine Procurement Towards equitable and affordable medicine prices policies in Jordan Workshop 4-5 Dec, 2007 Dr.
WHO STRATEGY FOR WORKING WITH COUNTRIES:REGIONAL AND COUNTRY PERSPECTIVE TECHNICAL BRIEFING SEMINAR,Geneva,19-23 September 2005 Dr. Jean-Marie TRAPSIDA.
Medication Management
World Health Organization
MEDICINES SELECTION & FORMULARY MANAGEMENT
Pharmaceuticals Procurement and Supply Management: The case of Ethiopia Cambodia, December 4,
Medicines Transparency Alliance (MeTA) Presented to CSO workshops during 2013 in SOLWEZI AUGUST 27 NDOLA AUGUST 29 LUSAKA OCTOBER 22.
1. Health Policy Research Group Department of Pharmacology & Therapeutics, College of Medicine, University of Nigeria Enugu Campus 2. Department of Clinical.
Rational Use of Injections within National Drug Policies World health organisation Essential Drugs and Medicines Policy Safe Injection Global Network Cairo.
PSK Annual Conference 2008 Palliative care medicine: A balanced approach to opioid availability and safe use in Kenya Presenter: Dr. Bilha Kiama-Murage.
Antibiotic Policy in Ghana; the way forward
International Experience in Pharmaceutical Services for Promoting Access to Medicines: Canada, Cuba, England, Mexico International Seminar on the Challenges.
Access to HIV/AIDS, Tuberculosis and Malaria Medicines. WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies. Geneva, 18 – 22 September.
1 Drug and Therapeutics Committee Session 10. Standard Treatment Guidelines.
Pharmaceutical Services Unit Essential Medicines Management MoH Procurement of Essential Medicines Presented by Mildred Mulenga Pharmacist, MoH 1.
Unit 8 Supply Chain. Objectives 1.Describe the special nature of health care commodities due to the need for provider advice and counseling 2.Describe.
Pharmaceutical System Strengthening : Bangladesh Perspective Aktari Mamtaz Joint Secretary Ministry of Health and Family welfare (MOHFW), Bangladesh.
EDM STRATEGY FOR WORKING WITH COUNTRIES-TANZANIA Rose Shija EDM NPO TANZANIA.
Essential Medicines Programmes Sudan now Essential Medicines Programmes Sudan now.
Procurement and Supply Management in Moldova Laurentiu IONESII.
3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.
National Medicine Policy
Prof. G. L. Monekosso WHO Regional Office for Africa.
UK Policy considerations on increasing access to medicines for the poor in developing countries. DEPARTMENT FOR INTERNATIONAL DEVELOPMENT.
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
WHO Perspective on Medicine Patents and FTAs Asian Regional Workshop on FTAs August, 2005, Kuala Lumpur, Malaysia Dr Zafar Mirza Regional Adviser,
HIV/AIDS and Trade Presentation by Ngoni Chibukire SAfAIDS 17 Beveridge Road Avondale Harare Tel: /4.
RHSC Meeting Kampala, May 2010 Quality for Medicines The Global Fund approach Sophie Logez Manager, QA and Data Quality Pharmaceutical Management.
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
25 Years of Essential Medicines … progress … unfinished agenda … promising developments Jonathan D. Quick, MD, MPH, Director Essential Drugs and Medicines.
10/22/2015 AER Social Politics & Public Health Committee 2, Katowice ( Slaskie, PL ) A REVIEW OF THE HEALTH SYSTEM IN ROMANIA
ACCESS TO MEDICINES - POLICY AND ISSUES
MALAWI GOVERNMENT MINISTRY OF HEALTH PROGRESS ON GOOD GOVERNANCE IN THE PHARMACEUTICAL SECTOR IN MALAWI By Dr Charles Mwansambo Secretary for Health 20.
Policy track summary ICIUM 2011 – 18 Nov Policy track topics 1.The pharmaceutical policy process 2.Quality and safety of medicines in LMIC 3.Policy.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Promoting Drug and Therapeutics Committees in the Developing World
Yemaneberhan Taddesse.  PASDEP(plan of accelerated and sustainable development for the Eradication of poverty) Poverty reduction strategy is the main.
Objective The aim was to assess purchasing pharmaceuticals in the public health sector in Jordan through the joint procurement for participating parties.
HEALTH A state of complete physical, mental and social well being and not merely the absence of disease or infirmity and ability to lead a socially and.
SARPAM Southern African Regional Programme for Access to Medicines and Diagnostics Presentation to Botswana TRIPS and Access to Medicines workshop 26 March.
1 Pharmaceutical System Strengthening: Is There a Need for a New Paradigm? Douglas Keene, PharmD, MHS ICIUM-3 Pre-Conference Session 14 November 2011.
PROVIDA’S IMPACT ON IMPROVING ACCESS TO AND USE OF ESSENTIAL DRUGS IN POOR COMMUNITIES IN PERU JOSEFA CASTRO, PHARMACIST JORGE SOLARI, PHYSICIAN SERVICIO.
WHO-Technical Briefing Seminar | October-November 2012 Dr Cécile Macé 1 |1 | Good Governance for Medicines Programme Dr Cécile Macé EMP/MPC.
Philippe Duneton11 February 2009 Deputy Executive Secretary 5th Consultative Stakeholder Meeting UN Prequalification of Diagnostics, Medicines & Vaccines.
TBS 2008-H. Tata & M. Babaley Mapping and In-depth Assessment of Medicines Procurement and Supply Systems WHO Technical Briefing Seminar 17 th -21 st November.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA RECAP ON PROCEEDINGS OF DAY 1 George Mpundu.
1 Patient Safety In China Gao Xinqiang 23 June 2014.
TBS Meeting Geneva, November 2010 Procurement and Supply Management Policies WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, November.
WHO Medicines Strategy Progress: Priorities: Dr Guitelle Baghdadi Essential Drugs and Medicines Policy World Health Organization November.
MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,
3rd WHO Prequalification Stakeholders Meeting :Diagnostics 3rd Stakeholders Meeting on Prequalification Geneva, 4th February 2008 Update on Prequalification.
RECENT ADVANCES IN PROVISION OF PRIMARY HEALTH CARE BY MISSION ORGANIZATIONS THE EFFECT OF AN EDUCATIONAL INTERVENTION ON USE OF ANTIBIOTICS IN THE TREATMENT.
PRACTICAL STEPS TO IMPLEMENTATION OF SRH AND HIV LINKAGES The Role of Government The Kingdom of Swaziland Experience Presented by Rejoice Nkambule Deputy.
Resource Creation: Health Technologies in Support of System Development Adham R Ismail, MS, MBA, PhD Biomedical Engineer Department of Health Systems &
SPECIAL SESSION COUNTDOWN TO 2015 IN ETHIOPIA SIX BUILDING BLOCKS OF THE HEALTH SYSTEM: PROGRESS TOWARDS THE INTEGRATION IN ETHIOPIA Dereje Mamo Tsegaye.
ADDRESSING PHARMACEUTICAL SUPPLY CHAIN NEEDS PRESENTATION TO HEALTH DONOR GROUP MEETING 8 July 2009.
Inter-American Development Bank
WHO Medicines Work in Countries: The Kenya Example
WHO Meeting of Interested Parties
Access to Medicines for HIV/AIDS, Tuberculosis and Malaria.
Richard Laing EMP/WHO TBS 2012
Lecture 9: PHC As a Strategy For HP Dr J. Sitali
Managing Procurement and Logistics of HIV/AIDS Drugs and Related Supplies Introduction and Overview May 30 to June 4, 2005 Abuja, Nigeria.
UNICEF Medicine Supply Systems Strengthening
Richard Laing WHO/PAU TBS 2013
Access to Essential Medicines
Interventions in the Kosovo Pharmaceutical Sector: Success or Failure?
Access to Essential Medicines
Presentation transcript:

Pharmaceutical Services Unit Essential Medicines Management Zambia: Towards Sustainable Access to Essential Medicines Presented by Chikuta Mbewe Pharmaceutical Services Unit

Pharmaceutical Services Unit Essential Medicines Management Outline: Objectives Introduction Why Worry about Medicines Public Health Objectives and the EMs Concept Defining & Improving Access to EMs Zambia Medicines Policy Goals and elements Challenges in Pharmaceutical Management Key Lessons for Zambia in P’ceutical Management Zambia’s position on TRIPS Pharmaceutical Services Unit

Pharmaceutical Services Unit Essential Medicines Management Objective: To describe current issues and opportunities in access to EMs Pharmaceutical Services Unit

Pharmaceutical Services Unit Essential Medicines Management Introduction Interest in human health is as old as humanity In developed countries modern pharmaceuticals has eliminated or radically reduced mortality from most infections, extended lives of millions In developing countries it is estimated that 60- 80% lack regular access to EMs Lack of access is directly proportional to income Pharmaceutical Services Unit

Pharmaceutical Services Unit Essential Medicines Management Why Worry so much about medicines Medicines save lives and improve health Medicines promote trust and participation in Health services Medicines cost money Medicines are different from other consumer products Substantive improvements in the supply and use of medicines are possible Pharmaceutical Services Unit

Pharmaceutical Services Unit Essential Medicines Management Public Health Objectives and the EMs Concept Public Health Programes are concerned with using available resources to achieve maximum health improvements In 1975 WHO defined EMs indispensable and necessary for the health needs of the population that need to be available all times in proper dosage forms Guiding principle is good selection (ZEML) and use (DTCs) Procurement and distribution economically and efficiently done with the few medicines Pharmaceutical Services Unit

Pharmaceutical Services Unit Essential Medicines Management Defining Access to EMs Isn’t access to health care including EMs a fundamental human right 4 dimensions of Access include availability (type and quantity needed Vs provided); -affordability (Pricing Vs ability to pay) -Accessibility (location of product Vs location of user -acceptability (satisfaction Vs expectations) Pharmaceutical Services Unit

Pharmaceutical Services Unit Essential Medicines Management Access to Medicines Policy Environment Zambia has a National Medicines Policy that was 1st promulgated in 1996 Zambia has a generic policy on procurement of EMs Has health related goals of increasing availability and accessibility to quality EMs Has economic goals that include lower cost of EMs, sustainable financing, job creation Has national development goals that include skills in pharmacy management Pharmaceutical Services Unit

Pharmaceutical Services Unit Essential Medicines Management Access to Medicines Policy Environment Selection Zambia has a NEML regularly updated Zambia National Formulary Committee is appointed body to oversee formulary activities Planning & Procurement Steady increase in the medicines budget Pharmaceutical Services Unit

Pharmaceutical Services Unit Essential Medicines Management Planning & Procurement National Essential Medicines Budget 2013 Budget Key Strengths 112% ↑ increase of drug budget from ZMK 270 Billion (2012) to ZMK 594 billion 248% ↑ for ARVs & 20% increase for EMs, TB, Laboratory, RHCs, vaccines, Cancer, Blood Products and 540% ↑ for medical supplies . ZMK 120 Billion for ACTs (latest budget-line for GRZ Pharmaceutical Services Unit

Pharmaceutical Services Unit Essential Medicines Management Distribution MoH strengthening equitable distribution systems for EMs through decentralization of MSL services 6 distribution hubs will be operationalization by end of 2015 Pharmaceutical Services Unit

Pharmaceutical Services Unit Essential Medicines Management Use has developed key essential medicines documents to improve use of medicines New editions (2013) available of ZNF, STGs, NEML, Guidelines of Medicines and Therapeutic Committees Pharmaceutical Services Unit

Pharmaceutical Services Unit Essential Medicines Management Regulation Reform of Pharmaceutical regulation completed in 2013 by repealing old Pharmaceutical Act and replacing it with the new Medicines & Allied Substances Act New act will increase access through regulated health shops to the Zambian Population Zambia very active on issues of regional harmonisation of pharmaceutical regulation Pharmaceutical Services Unit

Pharmaceutical Services Unit Essential Medicines Management National Challenges in Pharmaceutical Management Financing and sustainability (Public Health diseases including HIV/AIDS, TB, Malaria medicines is a high cost treatment category) Improving efficiencies in public supply system (weak distribution systems) Changing behaviours of providers and patients (irrational use of medicines) Regulating quality Pharmaceutical Services Unit

Pharmaceutical Services Unit Essential Medicines Management Key Lessons for Zambia in P’ceutical Management National Medicine Policy provides a sound foundation for managing pharmaceutical supply Wise selection of EMs underpins all other improvements Effective management and good governance saves resources Rational medicines is a practice issue Systematic assessment & monitoring are very essential Pharmaceutical Services Unit

Pharmaceutical Services Unit Essential Medicines Management TRIPS Vs Access in Zambia (Our Stand) Medicines are sacred commodities as they improve the quality of life and human development We have a right to better and dignified health We need PERMANENT exemptions from TRIPS Pharmaceutical Services Unit

Pharmaceutical Services Unit Essential Medicines Management Thank you for listening Pharmaceutical Services Unit